Evidence map›Paper›PMID 40075382›Full record

SynthesisJournal of translational medicine2025

Health-related quality of life in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Post COVID-19 Condition: a systematic review.

Breanna Weigel, Maira Inderyas, Natalie Eaton-Fitch, Kiran Thapaliya, Sonya Marshall-Gradisnik

Abstract readSystematic Review
In one paragraph

Synthesis in Journal of translational medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Breanna WeigelNational Centre for Neuroimmunology and Emerging Diseases, Griffith University, 1 Parklands Drive, Southport, Gold Coast, QLD, 4222, Australia. ncned@griffith.edu.au.ORCID 0000-0001-8452-6656
Maira InderyasNational Centre for Neuroimmunology and Emerging Diseases, Griffith University, 1 Parklands Drive, Southport, Gold Coast, QLD, 4222, Australia.ORCID 0009-0007-8655-9612
Natalie Eaton-FitchNational Centre for Neuroimmunology and Emerging Diseases, Griffith University, 1 Parklands Drive, Southport, Gold Coast, QLD, 4222, Australia.ORCID 0000-0002-0815-3162
Kiran ThapaliyaNational Centre for Neuroimmunology and Emerging Diseases, Griffith University, 1 Parklands Drive, Southport, Gold Coast, QLD, 4222, Australia.ORCID 0000-0002-7667-770X
Sonya Marshall-GradisnikNational Centre for Neuroimmunology and Emerging Diseases, Griffith University, 1 Parklands Drive, Southport, Gold Coast, QLD, 4222, Australia.ORCID 0000-0001-9270-2437

Funding

Alison Hunter Memorial Foundation 4570Blake Beckett Trust Foundation 4579Buxton Foundation 4676Change for ME Charity 4575Henty Community 4879Mason Foundation 47107McCusker Charitable Foundation 49979National Health and Medical Research Council 1199502Stafford Fox Medical Research Foundation 489798
6 · The paper itself

Abstract

purposeMyalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Post COVID-19 Condition (PCC) are debilitating, chronic multi-systemic illnesses that require multidisciplinary care. However, people with ME/CFS (pwME/CFS) and people with PCC (pwPCC) are often precluded from accessing necessary disability and social support services. These unmet care needs exacerbate the existing illness burdens experienced by pwME/CFS and pwPCC. To deliver appropriate care and optimise health outcomes for pwME/CFS and pwPCC, the development of evidence-based healthcare policies that recognise the disabling impacts of these illnesses must be prioritised. This systematic review summarises the health-related quality of life (HRQoL) of pwME/CFS and pwPCC when compared with healthy controls (HCs) to elucidate the impacts of these illnesses and guide healthcare policy reform.

methodsCINAHL, Embase, MEDLINE, PubMed, PsycINFO and the Web of Science Core Collection were systematically searched from 1st January 2003 to 23rd July 2024. Eligible publications included observational studies capturing quantitative HRQoL data among pwME/CFS or pwPCC when compared with HCs. The use of validated patient-reported outcome measures (PROMs) was mandatory. Eligible studies were also required to employ the most stringent diagnostic criteria currently available, including the Canadian Consensus Criteria or International Consensus Criteria for ME/CFS and the World Health Organization case definition for PCC (PROSPERO ID: CRD42024501309).

resultsThis review captured 16 studies, including eight studies among pwME/CFS, seven studies among pwPCC and one study among both illness cohorts. Most participants were female and middle-aged. All pwPCC had experienced prolonged COVID-19 symptoms for at least three months. When compared with HCs, all HRQoL domains were significantly impaired among pwME/CFS and pwPCC. Both illnesses had a salient impact on physical health, including pain and ability to perform daily and work activities. While direct comparisons between pwME/CFS and pwPCC were limited by inconsistencies in the PROMs employed, comparable impact trends across HRQoL domain scores were observed.

conclusionME/CFS and PCC have similar, profound impacts on HRQoL that warrant access to multidisciplinary disability and social support services. Future research must harmonise HRQoL data collection and prioritise longitudinal investigations among pwME/CFS and pwPCC to characterise PCC subgroups (including those fulfilling ME/CFS criteria) and predictors of prognosis.

Indexed as

COVID-19Fatigue Syndrome, ChronicQuality of LifeHumansSARS-CoV-2Health-related quality of lifeLong COVIDMyalgic Encephalomyelitis/Chronic Fatigue SyndromePost-Acute Sequelae of COVID-19Post COVID-19 Condition

Identifiers

PMID40075382
PMCPMC11905571

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.